Skip to content

Clinical Research of Live High 5-HTP Yield Bifidobacterium Longum Product on Depression Patients

Clinical Research of Live High 5-HTP Yield Bifidobacterium Longum Product on Depression Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127707
Enrollment
Unknown
Registered
2026-07-06
Start date
2025-09-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Group A: SSRIs+Placebo
:Conventional drug treatment Placebo
Group B: SSRIs+Probiotics:Conventional drug treatment, probiotic products (Goyi Jia Dual Probiotic Solid Beverage Daytime Pack)

Sponsors

The People's Hospital gaozhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 12 and 80; 2. HAM-D24 Depression Score above 20;

Exclusion criteria

Exclusion criteria: 1.Antibiotics are required two weeks before and during the treatment; 2.Severe diarrhea; 3.Participating in other clinical studies; 4.Serious lesions of important organs, organic diseases or other mental illness; 5.Allergic to lactic acid bacteria; 6.Depression caused by addictive chemicals; 7.Depression caused by psychoactive substances; 8.Have a severe suicidal tendency; 9.Preganant and breastfeeding people; 10.Other reasons which researchers believe are not suitable for clinical trials;

Design outcomes

Primary

MeasureTime frame
HAM-D24 score;

Secondary

MeasureTime frame
Changes in gut bacteria;

Countries

China

Contacts

Public ContactLiang Yan

The People's Hospital Gaozhou

gzlyan@126.com+86 668 638 9233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026